To assess the contribution of HO-1 expression over the integrity and phenotype of HSV-infected DCs, first, we evaluated the viability of bone-marrow-derived DCs (BMDCs) treated to express HO-1 and infected with either, HSV-1 or HSV-2 at 24 h post-infection (hpi). This evidence concerns the gene HMOX1 and infection.